141 related articles for article (PubMed ID: 23919297)
21. Herpesviruses: interfering innate immunity by targeting viral sensing and interferon pathways.
Kumari P; Narayanan S; Kumar H
Rev Med Virol; 2015 May; 25(3):187-201. PubMed ID: 25847408
[TBL] [Abstract][Full Text] [Related]
22. Danger, diversity and priming in innate antiviral immunity.
Collins SE; Mossman KL
Cytokine Growth Factor Rev; 2014 Oct; 25(5):525-31. PubMed ID: 25081316
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
Yang DR; Zhu HZ
World J Gastroenterol; 2015 Apr; 21(13):3786-800. PubMed ID: 25852264
[TBL] [Abstract][Full Text] [Related]
24. Interfering with immunity: detrimental role of type I IFNs during infection.
Stifter SA; Feng CG
J Immunol; 2015 Mar; 194(6):2455-65. PubMed ID: 25747907
[TBL] [Abstract][Full Text] [Related]
25. Enterovirus infections with special reference to enterovirus 71.
Hsiung GD; Wang JR
J Microbiol Immunol Infect; 2000 Mar; 33(1):1-8. PubMed ID: 10806956
[TBL] [Abstract][Full Text] [Related]
26. Strategies for immune evasion by human tumor viruses.
Bussey KA; Brinkmann MM
Curr Opin Virol; 2018 Oct; 32():30-39. PubMed ID: 30241043
[TBL] [Abstract][Full Text] [Related]
27. Coxsackievirus counters the host innate immune response by blocking type III interferon expression.
Lind K; Svedin E; Domsgen E; Kapell S; Laitinen OH; Moll M; Flodström-Tullberg M
J Gen Virol; 2016 Jun; 97(6):1368-1380. PubMed ID: 26935471
[TBL] [Abstract][Full Text] [Related]
28. Impairment of the type I interferon response by HIV-1: Potential targets for HIV eradication.
Sandstrom TS; Ranganath N; Angel JB
Cytokine Growth Factor Rev; 2017 Oct; 37():1-16. PubMed ID: 28455216
[TBL] [Abstract][Full Text] [Related]
29. Early IFN type I response: Learning from microbial evasion strategies.
Coccia EM; Battistini A
Semin Immunol; 2015 Mar; 27(2):85-101. PubMed ID: 25869307
[TBL] [Abstract][Full Text] [Related]
30. The game between host antiviral innate immunity and immune evasion strategies of senecavirus A - A cell biological perspective.
Zhao K; Zhang S; Liu X; Guo X; Guo Z; Zhang X; Yuan W
Front Immunol; 2022; 13():1107173. PubMed ID: 36618383
[TBL] [Abstract][Full Text] [Related]
31. Viral pathogen-induced mechanisms to antagonize mammalian interferon (IFN) signaling pathway.
Rojas JM; Alejo A; Martín V; Sevilla N
Cell Mol Life Sci; 2021 Feb; 78(4):1423-1444. PubMed ID: 33084946
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis E virus infection activates signal regulator protein α to down-regulate type I interferon.
Huang F; Yang C; Yu W; Bi Y; Long F; Wang J; Li Y; Jing S
Immunol Res; 2016 Feb; 64(1):115-22. PubMed ID: 26492885
[TBL] [Abstract][Full Text] [Related]
33. Innate immune evasion by picornaviruses.
Zhang X; Paget M; Wang C; Zhu Z; Zheng H
Eur J Immunol; 2020 Sep; 50(9):1268-1282. PubMed ID: 32767562
[TBL] [Abstract][Full Text] [Related]
34. Distinct Effects of Type I and III Interferons on Enteric Viruses.
Ingle H; Peterson ST; Baldridge MT
Viruses; 2018 Jan; 10(1):. PubMed ID: 29361691
[TBL] [Abstract][Full Text] [Related]
35. Recent advances from studies on the role of structural proteins in enterovirus infection.
Wen X; Cheng A; Wang M; Jia R; Zhu D; Chen S; Liu M; Sun K; Yang Q; Wu Y; Chen X
Future Microbiol; 2015; 10(9):1529-42. PubMed ID: 26343779
[TBL] [Abstract][Full Text] [Related]
36. Type I IFN--a blunt spear in fighting HIV-1 infection.
Acchioni C; Marsili G; Perrotti E; Remoli AL; Sgarbanti M; Battistini A
Cytokine Growth Factor Rev; 2015 Apr; 26(2):143-58. PubMed ID: 25466629
[TBL] [Abstract][Full Text] [Related]
37. Innate Immunity Evasion by Enteroviruses Linked to Epidemic Hand-Foot-Mouth Disease.
Jin Y; Zhang R; Wu W; Duan G
Front Microbiol; 2018; 9():2422. PubMed ID: 30349526
[TBL] [Abstract][Full Text] [Related]
38. The Intertwined Life Cycles of Enterovirus and Autophagy.
Mohamud Y; Luo H
Virulence; 2019 Dec; 10(1):470-480. PubMed ID: 30475087
[TBL] [Abstract][Full Text] [Related]
39. Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008.
Hsu CH; Lu CY; Shao PL; Lee PI; Kao CL; Chung MY; Chang LY; Huang LM
J Microbiol Immunol Infect; 2011 Aug; 44(4):265-73. PubMed ID: 21524954
[TBL] [Abstract][Full Text] [Related]
40. Suppression of interferon-α signaling by hepatitis E virus.
Dong C; Zafrullah M; Mixson-Hayden T; Dai X; Liang J; Meng J; Kamili S
Hepatology; 2012 May; 55(5):1324-32. PubMed ID: 22183878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
